SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla reached a new all-time high, fueling community discussions around its robotaxi strategy and battery expansion plans in Europe. Bullish sentiment appears strong, with some traders eyeing the $500 level and beyond, while others caution about stretched valuations and potential pullbacks. Discussions also include the company's long-term growth potential and competition in the EV market.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's potential $10B investment from OpenAI to utilize its AI chips is a hot topic, fueling discussions about the data center sector and analysts' target prices. The community is analyzing Amazon's infrastructure and AWS re-acceleration, while some express concerns about the investment's impact and potential market reactions, viewing it as an AI "circle jerk."

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new all-time highs, fueling community excitement and discussions around potential triple-digit prices. Community members are actively debating market manipulation, supply shortages, and the impact of industrial demand on silver's value. Some are noting JPM's shift to a long position as a bullish signal, while others caution against potential pullbacks and COMEX intervention.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending as investors discuss the company's upcoming product showcase, including AI improvements and expanded prediction markets. Community members are weighing the potential legal battles associated with prediction markets, while others focus on technical analysis and potential price movements. Broader market factors, such as Nasdaq's potential 23-hour trading and Bitcoin's performance, also influence the conversation around $HOOD.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members rally behind its vision of merging cannabis culture with cryptocurrency on the Solana blockchain. Discussions highlight Weedcoin's long-term potential, focus on community, and its connection to the broader cannabis industry and potential benefits of cannabis research. The coin is being positioned as a culture coin, like Bitcoin but way higher.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent merger and focus on robotics, with community members comparing it to past high-flying stocks. The stock's low float and high short interest are fueling speculation of a potential short squeeze, with many retail investors encouraging others to hold firm. Community members are actively discussing price targets and strategies to counter short sellers.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest updated revenue guidance for 2025 and 2026, with some analysts suggesting the lowered expectations are conservative. The community is actively discussing potential entry points, dividend safety, and whether the company is a turnaround play, while also debating the CEO's performance and future prospects. Some traders are taking short-term positions, while others focus on long-term value and accumulating shares.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as anticipation builds around potential cannabis rescheduling, fueled by reports of a possible executive order. The community is buzzing over the implications of rescheduling, particularly the potential for tax relief and increased institutional investment. Traders are closely watching for official confirmation and the resulting impact on US cannabis companies.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending due to the recent filing of its overdue Q2 report, which revealed a swing to profitability and a revenue increase. Community discussions revolve around the company's progress in meeting Nasdaq's compliance deadline and potential short squeeze opportunities. Investors are also considering the implications of the company's debt and ongoing regulatory matters.

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

DBV Technologies - ADR

DBV Technologies

DBV Technologies ($DBVT) is trending due to positive Phase 3 results for its VIASKIN Peanut patch, showing significant success in treating peanut allergies in children. The community is discussing the potential for FDA filing and the possibility of a squeeze, with attention focused on institutional buying and analyst target prices. Some investors are cautious, highlighting potential dilution risks and waiting for price confirmation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Piper Sandler downgraded ALEX stock to ‘Neutral’ from ‘Overweight’ and kept the price target unchanged at $21.</li><li>Alexander &amp; Baldwin announced on Monday that it would go private in a deal worth $2.3 billion.&nbsp;</li><li>The company will be acquired by a MW Group joint venture for $21.20 per share by the first quarter of 2026, the company said in a statement.&nbsp; &nbsp;</li></ul>Shares of Alexander &amp; Baldwin (ALEX) rallied over 38% on Tuesday morning after the announcement of the $2.3 billion take-private deal.The company’s outstanding shares will be acquired at $21.20 per share by a joint venture formed among MW Group, Blackstone Real Estate, and DivcoWest, expected to close by the first quarter of 2026. The all-cash deal represents a 40% premium to the company’s closing price as of Dec. 8, 2025.&nbsp;In addition, Alexander &amp; Baldwin announced a fourth-quarter (Q4) 2025 dividend of $0.35 per share, payable on January 8, 2026.&nbsp;<h2 class="st-heading-2">Street Action</h2>Meanwhile, Piper Sandler downgraded ALEX to ‘Neutral’ from ‘Overweight’ before, while keeping the price target intact at $21, as cited on TheFly. Piper said that it has revised its rating following the announcement and does not expect a competing bid to emerge.“Today, we are taking an important step toward our long-term vision for A&amp;B as stewards of Hawai'i's premier commercial real estate. As a private company supported by the deep real estate expertise and experience of our new ownership group, A&amp;B will have greater capacity to serve its tenants and communities,” President and CEO Lance Parker said.&nbsp;Alexander &amp; Baldwin is the only publicly traded real estate investment trust focused solely on Hawaiian commercial real estate. The company owns about four million square feet of commercial space in Hawai'i.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1276/154;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_09_at_8_30_30_PM_png_5f7959ea10.webp" alt="On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels." width="1276" height="154"></figure>Shares of ALEX have climbed over 18% in the past year and returned almost 30% in the last five years.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;

Generic Image of Office Space (Photo by Fairfax Media via Getty Images via Getty Images)

Alexander & Baldwin Shares Shoot Through The Roof After $2.3B Take Private Deal – This Firm Has Downgraded The Stock

Shares of ALEX surged over 38% in pre-market trading while Piper Sandler downgraded the stock. 

Equity

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced on Thursday that the U.S. Food and Drug Administration has approved a generic version of the Liraglutide injection known as Saxenda.Liraglutide Injection is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated to reduce excess body weight and maintain weight reduction long-term in adults as well as pediatric patients aged 12 years and older with body weight greater than 60 kg and obesity. The drug is to be used in combination with a reduced-calorie diet and increased physical activity.“With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S. the first ever generic GLP-1 product specifically indicated for weight loss,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-and-launch-of-generic-saxenda-liraglutide-injection--first-generic-glp-1-/">said</a> Ernie Richardsen, Head of U.S. Commercial Generics at Teva. He added that it marks an important addition to the company’s generics portfolio.Saxenda, Novo Nordisk’s older obesity drug, had annual sales of $165 million as of June 2025, the company said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> trended within ‘neutral’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:625/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_9_52_29_AM_png_ba7ec14e95.webp" alt="TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits" width="625" height="64"><figcaption>TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed surprise that the stock is not trading higher despite the approval.<stembedurl>https://stocktwits.com/RemitTekram/message/626845403</stembedurl>Another user sounded skeptical, saying that the stock would probably end the day in the red despite “explosive news.”<stembedurl>https://stocktwits.com/NoTradeAnymore/message/626842741</stembedurl>In the second quarter, Teva recorded revenue of $4.2 billion and adjusted and diluted earnings per share of $0.66. Generics product revenues in the U.S., however, fell 6% to $961 million, due to lower revenues from Lenalidomide capsules, the generic version of Revlimid, and Liraglutide injection 1.8mg, an authorized generic of Victoza, primarily driven by increased competition.TEVA stock is down 19% this year and approximately 3% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lakeshore-biopharma-receives-revised-proposal-to-acquire-company/chs6JRRRdmm">LakeShore Biopharma Receives Revised Proposal To Acquire Company</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A very overweight woman with swollen feet stands on a scale that reads 145.1 kilograms. Overweight and obesity are increasing at a rapid pace worldwide. Photo: Pia Bayer/dpa (Photo by Pia Bayer/picture alliance via Getty Images)

This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More

The company’s U.S. affiliate announced that the U.S. Food and Drug Administration has approved a generic version of Liraglutide injection, known as Saxenda.

BlackRock Institutional Trust Company N.A. - iShares Morningstar Multi-Asset Income ETF

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

IYLD
iShares Morningstar Multi-Asset Income ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IYLD News

IYLDiShares Morningstar Multi-Asset Income ETF